AI assistant
SOLARA ACTIVE PHARMA SCIENCES LIMITED — Call Transcript 2024
Jul 15, 2024
61842_rns_2024-07-15_633a4acd-afaa-480f-9ed0-640a06b385a9.pdf
Call Transcript
Open in viewerOpens in your device viewer
Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block
27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : [email protected] www.solara.co.in
Keelakottaiyur Village, Melakottaiyur (Post)
July 15, 2024
The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Scrip Code: 541540
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051
Scrip Code: SOLARA
Dear Sir / Madam,
Subject: Intimation of Analysts / Institutional Investors Conference Call
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Monday, July 22, 2024, at 3:30 pm IST to discuss its Q1 financial results. The conference call details are as follows:
| Event | Date & Time | Phone Numbers |
|---|---|---|
| Post Results Q1 FY25 Conference Call |
Monday, July 22, 2024, at 3:30 pm IST |
+91 22 6280 1346 +91 22 7115 8247 |
| URL for prior (early) registration https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=9809185&linkSec urityString=3dea7c14a6 |
This is for your information and records.
Thanking you, Yours faithfully, For Solara Active Pharma Sciences Limited
SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2024.07.15 11:25:01 +05'30'
S. Murali Krishna Company Secretary
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Solara Conference Call Monday, 22[nd] July 2024, 3:30 pm IST
. Pure play APIs SOLARA ACTIVE PHARMA SCIENCES | July’24
Arun Kumar, Founder & Non-Executive Director Poorvank Purohit, MD & CEO Arun Kumar Baskaran, CFO
Dial in Details: For Solara’s conference call, Monday 22[nd] July 2024, 3:30 pm IST Universal Access +91 22 6280 1346 +91 22 7115 8247
==> picture [208 x 240] intentionally omitted <==
Copy this URL in your https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber browser =9809185&linkSecurityString=3dea7c14a6 (for early registration)
1